Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
Neurologic Manifestations Seen in Most Hospitalized With COVID-19
Encephalopathy, seen in 31.8 percent of hospitalized patients, tied to worse functional outcome, mortality
Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
ACS: Antibiotics Noninferior to Appendectomy for Appendicitis
However, complications occurred more often in the antibiotics group than in the appendectomy group
Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
CLABSI Rates Have Remained Stable in Neonatal, Pediatric ICUs
However, 2013 to 2018 saw decrease in population-based CAUTI rates, indwelling urinary catheter use
Fecal Transplant Safe, Effective for C. Difficile Through Six Months
90 percent of those undergoing FMT had one-month cure; 4 percent had recurrence within six months
Pandemic-Induced Impairments in Work Impact Mental Health
Impairments in work and social functioning strongly linked with elevated depression, anxiety symptoms
2018 to 2019 Vaccine Cut Influenza A-Linked Hospitalizations
Influenza vaccine reduced pediatric influenza A-linked hospitalizations, ED visits by 40 to 60 percent
